Skip to main content
Erschienen in: Neurological Sciences 11/2014

01.11.2014 | Original Article

The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model

verfasst von: Emilio Russo, Paolo Follesa, Rita Citraro, Caterina Camastra, Annalidia Donato, Daniela Isola, Andrew Constanti, Giovambattista De Sarro, Giuseppe Donato

Erschienen in: Neurological Sciences | Ausgabe 11/2014

Einloggen, um Zugang zu erhalten

Abstract

Hyperactivation of mammalian target of rapamycin (mTOR) signaling pathway occurs after an epileptogenic insult and, its inhibition prevents the development of spontaneous seizures. We have recently demonstrated that mTOR’s inhibition by rapamycin (started before seizure onset), permanently reduces the development of spontaneous absence seizures in WAG/Rij rats, an animal model of absence epilepsy; furthermore, mTOR phosphorylation was increased in adult WAG/Rij rats’ cortex, but not other brain areas. However, it was not clear whether this hyperphosphorylation was a cause or a consequence of absence seizure. Here, we have addressed this issue by analyzing immunohistochemically: (1) the brain levels of total and phosphorylated mTOR in young (before seizures) and adult WAG/Rij rats; (2) the proliferation of hippocampal neuronal stem/progenitor cells assessed by BrdU analysis at different ages. WAG/Rij rats have higher levels of total mTOR in several brain areas than Wistar rats; phospho-mTOR staining is higher in young WAG/Rij rats than control and adult WAG/Rij rats. Finally, the age-related decline in hippocampal neural progenitor cell proliferation rate was slower in WAG/Rij than Wistar rats. Our results support a role for persistent mTOR activation and consequent change in hippocampal progenitor cell proliferation during the epileptogenic process leading to the development of absence seizures in WAG/Rij rats.
Literatur
4.
Zurück zum Zitat van Luijtelaar G, Zobeiri M (2014) Progress and outlooks in a genetic absence epilepsy model (WAG/Rij). Curr Med Chem 21(6):704–721PubMedCrossRef van Luijtelaar G, Zobeiri M (2014) Progress and outlooks in a genetic absence epilepsy model (WAG/Rij). Curr Med Chem 21(6):704–721PubMedCrossRef
5.
Zurück zum Zitat Russo E, Citraro R, Scicchitano F, De Fazio S, Perrotta I, Di Paola ED, Constanti A, De Sarro G (2011) Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia 52(7):1341–1350. doi:10.1111/j.1528-1167.2011.03112.x PubMedCrossRef Russo E, Citraro R, Scicchitano F, De Fazio S, Perrotta I, Di Paola ED, Constanti A, De Sarro G (2011) Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia 52(7):1341–1350. doi:10.​1111/​j.​1528-1167.​2011.​03112.​x PubMedCrossRef
6.
Zurück zum Zitat Russo E, Citraro R, Scicchitano F, Urzino A, Marra R, Rispoli V, De Sarro G (2011) Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity. Behav Brain Res 225(1):373–376. doi:10.1016/j.bbr.2011.07.030 PubMedCrossRef Russo E, Citraro R, Scicchitano F, Urzino A, Marra R, Rispoli V, De Sarro G (2011) Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity. Behav Brain Res 225(1):373–376. doi:10.​1016/​j.​bbr.​2011.​07.​030 PubMedCrossRef
7.
8.
Zurück zum Zitat Russo E, Citraro R, Scicchitano F, De Fazio S, Di Paola ED, Constanti A, De Sarro G (2010) Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia 51(8):1560–1569. doi:10.1111/j.1528-1167.2009.02400.x PubMedCrossRef Russo E, Citraro R, Scicchitano F, De Fazio S, Di Paola ED, Constanti A, De Sarro G (2010) Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia 51(8):1560–1569. doi:10.​1111/​j.​1528-1167.​2009.​02400.​x PubMedCrossRef
9.
Zurück zum Zitat Sandsmark DK, Pelletier C, Weber JD, Gutmann DH (2007) Mammalian target of rapamycin: master regulator of cell growth in the nervous system. Histol Histopathol 22(8):895–903PubMed Sandsmark DK, Pelletier C, Weber JD, Gutmann DH (2007) Mammalian target of rapamycin: master regulator of cell growth in the nervous system. Histol Histopathol 22(8):895–903PubMed
10.
Zurück zum Zitat Paliouras GN, Hamilton LK, Aumont A, Joppe SE, Barnabe-Heider F, Fernandes KJ (2012) Mammalian target of rapamycin signaling is a key regulator of the transit-amplifying progenitor pool in the adult and aging forebrain. J Neurosci 32(43):15012–15026. doi:10.1523/JNEUROSCI.2248-12.2012 PubMedCrossRef Paliouras GN, Hamilton LK, Aumont A, Joppe SE, Barnabe-Heider F, Fernandes KJ (2012) Mammalian target of rapamycin signaling is a key regulator of the transit-amplifying progenitor pool in the adult and aging forebrain. J Neurosci 32(43):15012–15026. doi:10.​1523/​JNEUROSCI.​2248-12.​2012 PubMedCrossRef
12.
Zurück zum Zitat Citraro R, Scicchitano F, De Fazio S, Raggio R, Mainardi P, Perucca E, De Sarro G, Russo E (2011) Preclinical activity profile of alpha-lactalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. Epilepsy Res 95(1–2):60–69. doi:10.1016/j.eplepsyres.2011.02.013 PubMedCrossRef Citraro R, Scicchitano F, De Fazio S, Raggio R, Mainardi P, Perucca E, De Sarro G, Russo E (2011) Preclinical activity profile of alpha-lactalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. Epilepsy Res 95(1–2):60–69. doi:10.​1016/​j.​eplepsyres.​2011.​02.​013 PubMedCrossRef
13.
Zurück zum Zitat Citraro R, Russo E, Scicchitano F, van Rijn CM, Cosco D, Avagliano C, Russo R, D’Agostino G, Petrosino S, Guida F, Gatta L, van Luijtelaar G, Maione S, Di Marzo V, Calignano A, De Sarro G (2013) Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-alpha receptor activation in a genetic model of absence epilepsy. Neuropharmacology 69:115–126. doi:10.1016/j.neuropharm.2012.11.017 PubMedCrossRef Citraro R, Russo E, Scicchitano F, van Rijn CM, Cosco D, Avagliano C, Russo R, D’Agostino G, Petrosino S, Guida F, Gatta L, van Luijtelaar G, Maione S, Di Marzo V, Calignano A, De Sarro G (2013) Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-alpha receptor activation in a genetic model of absence epilepsy. Neuropharmacology 69:115–126. doi:10.​1016/​j.​neuropharm.​2012.​11.​017 PubMedCrossRef
14.
Zurück zum Zitat Russo E, Scicchitano F, Citraro R, Aiello R, Camastra C, Mainardi P, Chimirri S, Perucca E, Donato G, De Sarro G (2012) Protective activity of alpha-lactalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. Neuroscience 226:282–288. doi:10.1016/j.neuroscience.2012.09.021 PubMedCrossRef Russo E, Scicchitano F, Citraro R, Aiello R, Camastra C, Mainardi P, Chimirri S, Perucca E, Donato G, De Sarro G (2012) Protective activity of alpha-lactalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. Neuroscience 226:282–288. doi:10.​1016/​j.​neuroscience.​2012.​09.​021 PubMedCrossRef
15.
Zurück zum Zitat Citraro R, Russo E, Gratteri S, Di Paola ED, Ibbadu GF, Curinga C, Gitto R, Chimirri A, Donato G, De Sarro G (2006) Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology 51(6):1058–1067. doi:10.1016/j.neuropharm.2006.06.014 PubMedCrossRef Citraro R, Russo E, Gratteri S, Di Paola ED, Ibbadu GF, Curinga C, Gitto R, Chimirri A, Donato G, De Sarro G (2006) Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology 51(6):1058–1067. doi:10.​1016/​j.​neuropharm.​2006.​06.​014 PubMedCrossRef
16.
Zurück zum Zitat Macias M, Blazejczyk M, Kazmierska P, Caban B, Skalecka A, Tarkowski B, Rodo A, Konopacki J, Jaworski J (2013) Spatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatment. PLoS ONE 8(5):e64455. doi:10.1371/journal.pone.0064455 PubMedCentralPubMedCrossRef Macias M, Blazejczyk M, Kazmierska P, Caban B, Skalecka A, Tarkowski B, Rodo A, Konopacki J, Jaworski J (2013) Spatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatment. PLoS ONE 8(5):e64455. doi:10.​1371/​journal.​pone.​0064455 PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH (1998) Neurogenesis in the adult human hippocampus. Nat Med 4(11):1313–1317PubMedCrossRef Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH (1998) Neurogenesis in the adult human hippocampus. Nat Med 4(11):1313–1317PubMedCrossRef
21.
Zurück zum Zitat Kuhn HG, Dickinson-Anson H, Gage FH (1996) Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16(6):2027–2033PubMed Kuhn HG, Dickinson-Anson H, Gage FH (1996) Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16(6):2027–2033PubMed
22.
Zurück zum Zitat Coggeshall RE, Lekan HA (1996) Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 364(1):6–15PubMedCrossRef Coggeshall RE, Lekan HA (1996) Methods for determining numbers of cells and synapses: a case for more uniform standards of review. J Comp Neurol 364(1):6–15PubMedCrossRef
23.
Zurück zum Zitat Russo E, Citraro R, Davoli A, Gallelli L, Di Paola ED, De Sarro G (2013) Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology 64:371–379. doi:10.1016/j.neuropharm.2012.06.039 PubMedCrossRef Russo E, Citraro R, Davoli A, Gallelli L, Di Paola ED, De Sarro G (2013) Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology 64:371–379. doi:10.​1016/​j.​neuropharm.​2012.​06.​039 PubMedCrossRef
24.
Zurück zum Zitat Citraro R, Russo E, Ngomba RT, Nicoletti F, Scicchitano F, Whalley BJ, Calignano A, De Sarro G (2013) CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations. Epilepsy Res 106(1–2):74–82. doi:10.1016/j.eplepsyres.2013.06.004 PubMedCrossRef Citraro R, Russo E, Ngomba RT, Nicoletti F, Scicchitano F, Whalley BJ, Calignano A, De Sarro G (2013) CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations. Epilepsy Res 106(1–2):74–82. doi:10.​1016/​j.​eplepsyres.​2013.​06.​004 PubMedCrossRef
26.
Zurück zum Zitat Shetty AK, Hattiangady B, Shetty GA (2005) Stem/progenitor cell proliferation factors FGF-2, IGF-1, and VEGF exhibit early decline during the course of aging in the hippocampus: role of astrocytes. Glia 51(3):173–186. doi:10.1002/glia.20187 PubMedCrossRef Shetty AK, Hattiangady B, Shetty GA (2005) Stem/progenitor cell proliferation factors FGF-2, IGF-1, and VEGF exhibit early decline during the course of aging in the hippocampus: role of astrocytes. Glia 51(3):173–186. doi:10.​1002/​glia.​20187 PubMedCrossRef
Metadaten
Titel
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model
verfasst von
Emilio Russo
Paolo Follesa
Rita Citraro
Caterina Camastra
Annalidia Donato
Daniela Isola
Andrew Constanti
Giovambattista De Sarro
Giuseppe Donato
Publikationsdatum
01.11.2014
Verlag
Springer Milan
Erschienen in
Neurological Sciences / Ausgabe 11/2014
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-014-1842-1

Weitere Artikel der Ausgabe 11/2014

Neurological Sciences 11/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.